Home
About
Overview
Sharing Data
ORCID
Help
History (1)
PROX1 gene variant is associated with fasting glucose change after antihypertensive treatment.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
PROX1 gene variant is associated with fasting glucose change after antihypertensive treatment.
PROX1 gene variant is associated with fasting glucose change after antihypertensive treatment. Pharmacotherapy. 2014 Feb; 34(2):123-30.
View in:
PubMed
subject areas
Adrenergic beta-Antagonists
Adult
Antihypertensive Agents
Atenolol
Blood Glucose
Drug Therapy, Combination
Fasting
Female
Homeodomain Proteins
Humans
Hydrochlorothiazide
Hyperglycemia
Hypertension
Linear Models
Male
Middle Aged
Pharmacogenetics
Polymorphism, Single Nucleotide
Risk Factors
Tumor Suppressor Proteins
authors with profiles
Arlene Chapman